JP2020534351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534351A5 JP2020534351A5 JP2020534793A JP2020534793A JP2020534351A5 JP 2020534351 A5 JP2020534351 A5 JP 2020534351A5 JP 2020534793 A JP2020534793 A JP 2020534793A JP 2020534793 A JP2020534793 A JP 2020534793A JP 2020534351 A5 JP2020534351 A5 JP 2020534351A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cdr
- tm4sf1
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023033463A JP2023071888A (ja) | 2017-08-28 | 2023-03-06 | 抗ｔｍ４ｓｆ１抗体およびそれを使用する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762550994P | 2017-08-28 | 2017-08-28 | |
| US62/550,994 | 2017-08-28 | ||
| PCT/US2018/048402 WO2019046338A1 (en) | 2017-08-28 | 2018-08-28 | ANTI-TM4SF1 ANTIBODIES AND METHODS OF USE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023033463A Division JP2023071888A (ja) | 2017-08-28 | 2023-03-06 | 抗ｔｍ４ｓｆ１抗体およびそれを使用する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020534351A JP2020534351A (ja) | 2020-11-26 |
| JP2020534351A5 true JP2020534351A5 (https=) | 2021-10-07 |
| JP7241080B2 JP7241080B2 (ja) | 2023-03-16 |
Family
ID=65526015
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020534793A Active JP7241080B2 (ja) | 2017-08-28 | 2018-08-28 | 抗ｔｍ４ｓｆ１抗体およびそれを使用する方法 |
| JP2023033463A Pending JP2023071888A (ja) | 2017-08-28 | 2023-03-06 | 抗ｔｍ４ｓｆ１抗体およびそれを使用する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023033463A Pending JP2023071888A (ja) | 2017-08-28 | 2023-03-06 | 抗ｔｍ４ｓｆ１抗体およびそれを使用する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11208495B2 (https=) |
| EP (1) | EP3675906A4 (https=) |
| JP (2) | JP7241080B2 (https=) |
| CN (1) | CN111565750B (https=) |
| AU (1) | AU2018323470B2 (https=) |
| CA (1) | CA3074111A1 (https=) |
| MX (1) | MX2020002241A (https=) |
| WO (1) | WO2019046338A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10265497B2 (en) | 2015-11-24 | 2019-04-23 | Massachusetts Institute Of Technology | Systems and methods for treating dementia |
| KR20250153860A (ko) | 2016-11-17 | 2025-10-27 | 코그니토 쎄라퓨틱스, 인코포레이티드 | 시각 자극을 통한 신경 자극 방법 및 시스템 |
| MX2020002241A (es) * | 2017-08-28 | 2020-09-03 | Angiex Inc | Anticuerpos anti-tm4sf y métodos de uso de los mismos. |
| US10960225B2 (en) | 2017-10-10 | 2021-03-30 | Massachusetts Institute Of Technology | Systems and methods for preventing, mitigating, and/or treating dementia via visual stimulation that binds higher order brain regions, reduces neurodegeneration and neuroinflammation, and improves cognitive function |
| KR102706443B1 (ko) | 2017-10-10 | 2024-09-11 | 메사추세츠 인스티튜트 오브 테크놀로지 | 치매를 예방, 경감 및/또는 치료하기 위한 시스템 및 방법 |
| CA3103265A1 (en) * | 2018-06-12 | 2019-12-19 | Angiex, Inc. | Antibody-oligonucleotide conjugates |
| US12428477B2 (en) | 2019-02-27 | 2025-09-30 | Angiex, Inc. | Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same |
| CN110734494B (zh) * | 2019-10-30 | 2021-04-30 | 上海市第一人民医院 | 抗tspan8单克隆抗体及其用途 |
| JP2023520371A (ja) * | 2020-03-27 | 2023-05-17 | アンジーエックス・インコーポレーテッド | デグレーダー分子－抗体コンジュゲートおよびその使用方法 |
| WO2021222783A1 (en) * | 2020-05-01 | 2021-11-04 | Angiex, Inc. | Anti-tm4sf1 antibody drug conjugates and methods of using same |
| WO2022026915A2 (en) * | 2020-07-31 | 2022-02-03 | Angiex, Inc. | Anti-tm4sf1 antibody-drug conjugates comprising cleavable linkers and methods of using same |
| EP4204013A4 (en) * | 2020-08-26 | 2025-04-16 | Angiex, Inc. | ANTIMITOTIC TETRAPEPTIDE-ANTIBODY CONJUGATES AND METHODS OF USE THEREOF |
| AU2022245388A1 (en) * | 2021-03-26 | 2023-10-05 | Angiex, Inc. | Maytansine-antibody conjugates and methods of using same |
| EP4313144A4 (en) * | 2021-03-26 | 2025-08-20 | Angiex Inc | COMBINATIONS COMPRISING ANTI-TM4SF1 ANTIBODIES AND IMMUNOTHERAPY AGENTS AND METHODS OF USE THEREOF |
| JPWO2022255401A1 (https=) * | 2021-06-03 | 2022-12-08 | ||
| BR112023025305A2 (pt) * | 2021-06-03 | 2024-02-27 | Medpacto Inc | Composições farmacêuticas, proteína de fusão, e, uso do inibidor do membro 19 da família 4 l seis da transmembrana |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| WO1988007089A1 (en) | 1987-03-18 | 1988-09-22 | Medical Research Council | Altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| EP0519596B1 (en) | 1991-05-17 | 2005-02-23 | Merck & Co. Inc. | A method for reducing the immunogenicity of antibody variable domains |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
| ES2375931T3 (es) | 1997-12-05 | 2012-03-07 | The Scripps Research Institute | Humanización de anticuerpo murino. |
| ES2292236T3 (es) | 1998-04-02 | 2008-03-01 | Genentech, Inc. | Variantes de anticuerpos y sus fragmentos. |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| AU2003225669A1 (en) | 2002-09-26 | 2004-04-19 | Pintex Pharmaceuticals, Inc. | Pin1-modulating compounds and methods of use thereof |
| US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| CN1961003B (zh) | 2004-03-31 | 2013-03-27 | 健泰科生物技术公司 | 人源化抗TGF-β抗体 |
| ES2776406T3 (es) | 2007-07-12 | 2020-07-30 | Gitr Inc | Terapias de combinación que emplean moléculas de enlazamiento a GITR |
| HRP20160855T1 (hr) | 2008-02-08 | 2016-09-23 | Medimmune, Llc | Anti-ifnar1 protutijela sa smanjenim afinitetom fc liganda |
| EP2385114A4 (en) * | 2008-12-25 | 2012-08-08 | Univ Tokyo | CANCER TREATMENT DIAGNOSIS WITH ANTI-TM4SF20 ANTIBODY |
| SG10201602394QA (en) | 2011-03-29 | 2016-05-30 | Roche Glycart Ag | Antibody FC Variants |
| WO2012145746A1 (en) | 2011-04-21 | 2012-10-26 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for the treatment of neuromyelitis optica |
| CN102590531A (zh) * | 2012-03-24 | 2012-07-18 | 广西壮族自治区肿瘤防治研究所 | 卵巢癌相关抗原自身抗体谱液相芯片检测试剂盒及其制备方法 |
| WO2015054427A1 (en) * | 2013-10-10 | 2015-04-16 | Beth Israel Deaconess Medical Center, Inc. | Tm4sf1 binding proteins and methods of using same |
| KR102515248B1 (ko) | 2013-11-22 | 2023-03-29 | 사브레 테라퓨틱스 엘엘씨 | 오토탁신 억제제 화합물 |
| SG10201912986PA (en) * | 2014-05-28 | 2020-02-27 | Agenus Inc | Anti-gitr antibodies and methods of use thereof |
| MX2020002241A (es) * | 2017-08-28 | 2020-09-03 | Angiex Inc | Anticuerpos anti-tm4sf y métodos de uso de los mismos. |
-
2018
- 2018-08-28 MX MX2020002241A patent/MX2020002241A/es unknown
- 2018-08-28 JP JP2020534793A patent/JP7241080B2/ja active Active
- 2018-08-28 WO PCT/US2018/048402 patent/WO2019046338A1/en not_active Ceased
- 2018-08-28 CN CN201880070504.7A patent/CN111565750B/zh active Active
- 2018-08-28 AU AU2018323470A patent/AU2018323470B2/en active Active
- 2018-08-28 CA CA3074111A patent/CA3074111A1/en active Pending
- 2018-08-28 EP EP18849908.1A patent/EP3675906A4/en active Pending
- 2018-08-28 US US16/642,995 patent/US11208495B2/en active Active
-
2021
- 2021-11-22 US US17/532,664 patent/US20220153860A1/en not_active Abandoned
- 2021-11-22 US US17/532,660 patent/US20220267461A1/en not_active Abandoned
-
2023
- 2023-03-06 JP JP2023033463A patent/JP2023071888A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020534351A5 (https=) | ||
| US11136413B2 (en) | PDL-1 antibody, pharmaceutical composition thereof, and uses thereof | |
| IL293241A (en) | Bispecific antibody, anti-1-pd, anti-vegfa, pharmaceutical preparation containing it and its use | |
| JP2020520665A5 (https=) | ||
| AU2019356806B2 (en) | Antibody constructs binding 4-1BB and tumor-associated antigens and uses thereof | |
| JP2016514676A (ja) | 四価二重特異性抗体 | |
| JPWO2021104302A5 (https=) | ||
| WO2023060277A1 (en) | Composition of multispecific antibodies targeting cdh17-expressing tumors and method of making and using thereof | |
| KR20210027254A (ko) | Tim-3에 대한 항체 및 그의 용도 | |
| CN112166125A (zh) | 全人源的抗lag-3抗体及其应用 | |
| JPWO2021019389A5 (https=) | ||
| US20230265202A1 (en) | Antibody constructs binding 4-1bb and folate receptor alpha and uses thereof | |
| JP7811028B2 (ja) | ヒトｃｘｃｌ１６抗体およびその使用 | |
| CN114269784A (zh) | 具有选择性可切割接头的双特异性结合构建体 | |
| TW202506193A (zh) | Trop2結合劑及其結合物 | |
| JPWO2021213475A5 (https=) | ||
| JPWO2019170885A5 (https=) | ||
| CN116783217A (zh) | 具有多个结合结构域的免疫球蛋白构建体 | |
| JPWO2023051683A5 (https=) | ||
| US20260109769A1 (en) | Pd-1 bnding proteins, vegf and pd-1 bispecific binding proteins, compositions, and methods of use | |
| JPWO2023026236A5 (https=) | ||
| WO2024141049A1 (zh) | 抗ox40抗体及其应用 | |
| TW202535936A (zh) | 靶向liv-1之抗體及其用途 | |
| RU2024107310A (ru) | Радиоконъюгаты к psma и способы их применения | |
| JPWO2022010847A5 (https=) |